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Abstract There are many disorders that may involve the
left ventricular (LV) apex; however, they are sometimes
difficult to differentiate. In this setting cardiac imaging
methods can provide the clue to obtaining the diagnosis.
The purpose of this review is to illustrate the spectrum of
diseases that most frequently affect the apex of the LV
including Tako-Tsubo cardiomyopathy, LV aneurysms
and pseudoaneurysms, apical diverticula, apical ventric-
ular remodelling, apical hypertrophic cardiomyopathy,
LV non-compaction, arrhythmogenic right ventricular
dysplasia with LV involvement and LV false tendons,
with an emphasis on the diagnostic criteria and imaging
features.
Keywords Cardiac aneurysm.Left ventricular
remodelling.Left ventricular hypertrophy.Tako-Tsubo
cardiomyopathy.Isolated non-compaction of the ventricular
myocardium
Introduction
The left ventricle (LV) is affected by many diseases with
different clinical and morphological features. Within this
broad spectrum, a subset of heterogeneous diseases is
characterised as preferentially affecting the LV apex.
Generally LV assessment begins with echocardiography
because of its wide availability and because it is fast, low-
priced, portable and robust in experienced hands. However,
because of intrinsic or technical limitations (limited field of
vision, inadequate acoustic window, inability to definitively
depict the endocardial border, especially the anterolateral
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view and the apex) [1, 2] and technical artefacts (reverber-
ations, near-field artefacts), in such cases further investiga-
tion, usually with magnetic resonance (MR) imaging,
which is the method of choice for the diagnosis of
myocardial diseases, may be necessary. MR imaging is
less dependent on the operator and is not subject to acoustic
window limitations [3]. Due to their high spatial and
temporal resolution, MR and CT can clearly visualise the
apex of the LV, but CT is not yet recommended as the
method of primary choice in the case of suspected left
ventricular apical disease. Cine MR imaging with the
steady-state free precession pulse sequence can offer the
advantages of multiplanar imaging, complete coverage of
the entire myocardium without obliquity, and excellent soft-
tissue contrast between the myocardial border and the
blood pool [4, 5]. In addition, the status of myocardial
blood flow can be assessed by using adenosine stress
cardiac MR imaging. Delayed enhancement MR imaging
techniques can provide unique information for tissue
characterisation, specifically for the identification of
myocardial fibrosis or scarring [6, 7]. CT has also emerged
as a novel technique for evaluating cardiac morphology
and function, as well as the coronary artery. Compared
with the spatial resolution of MR imaging, that of
multidetector CT is usually higher [8]. Therefore, cardiac
multidetector CT can offer anatomical and functional
information about the cardiac chambers and a high-
quality non-invasive coronary angiography [9, 10]. Multi-
detector CT would be more appropriate in those cases for
which there are specific requests to exclude coronary
artery disease and in those with contraindications for MR
imaging, such as the patient having a pacemaker [11].
Therefore, radiologists play an increasing role in the
evaluation of LV apical abnormalities, thus requiring a
greater awareness and familiarity with this diseases.
The aim of this paper is to illustrate the spectrum of
diseases that most frequently affect the apex of the LV,
with an emphasis on the diagnostic criteria and imaging
features.
Normal findings
Myocardial thinning (one of the principal signs of myocar-
dial injury) is an important observation in patients
suspected of having had ischaemic insults to the heart.
However, thinning of the LV apex has been described by
anatomists as a normal feature. With the advent of motion-
gated cross-sectional cardiac imaging, normal apical thin-
ning can be quite noticeable, especially on computed
tomography (CT) in which the spatial resolution is
submillimetre [12, 13].
Ischaemia-related diseases
Magnetic resonance imaging has increasing potential in the
non-invasive evaluation of patients with myocardial infarc-
tion and subsequent complications. The low interobserver
variability and the high interstudy reproducibility of MR
imaging for quantifying LV volume, wall thickening and
mass make it an attractive imaging technique for follow-up
Fig. 1 Patient with antecedent of myocardial infarction. Contrast-
enhanced CT (CECT) shows a small amount of contrast medium
outside the ventricular wall due to a pseudoaneurysm (white arrow).
Note that the calcifications formed as a result of necrosis define the
ventricular wall
Aneurysms Pseudoaneurysms Congenital diverticula
Layers All layers of the
ventricular myocardium
Organized hematoma
and pericardium
All layers of the
ventricular
myocardium
Cine Akinetic or dyskinetic
segment
Akinetic or dyskinetic
segment
Shows contraction
during systole
Myocardial late
enhancement
Yes No, only the border of the
pseudoaneurysm will show
enhancement
No
Pericardial late
enhancement
No or faint Marked No
Table 1 Differences among
aneurysms, pseudoaneurysms
and congenital diverticula
472 Insights Imaging (2011) 2:471–482studies in patients with ischaemic coronary artery disease
and LV remodelling after infarction [14–16] . Moreover,
MR imaging can clearly localise the site of the aneurysm,
pseudoaneurysm or diverticula, is capable of distinguishing
among pericardium, thrombus and myocardium, and
delayed enhancement MR imaging helps in the differenti-
ation between a true aneurysm and a pseudoaneurysm [17].
Apical aneurysm and pseudoaneurysm
Pseudoaneurysms or false aneurysms are defined as a rupture
of the myocardium that is contained by pericardial adhesions.
A pseudoaneurysm usually represents a rare complication of
myocardial infarction (Fig. 1,V i d e o1 and 2) ,b u ti tm a y
also occur after cardiac surgery, chest trauma and
endocarditis [18]. They can occur in different locations,
but the purpose of this paper is to describe those arising
from the apex of the LV. The wall of a false aneurysm is
composedoforganisedhaematomaandpericardium(Table1).
Pathological examination shows fibrous tissue and lacks the
myocardial elements that are usually seen in the wall of true
aneurysms [18].
Conversely, a true aneurysm, which occurs in 5–10% of
patients with acute myocardial infarction, contains the
endocardium, epicardium and a predominantly fibrous
tissue that has replaced myocardium in its wall [17]. An
important difference is the lower rupture potential of a true
aneurysm compared with a pseudoaneurysm. Surgical
repair is the treatment of choice for pseudoaneurysms,
while true aneurysms, in the absence of other surgical
indications (i.e. refractory angina pectoris, congestive heart
failure, systemic embolisation or refractory arrhythmia) are
treated medically [18, 19]. Cine MR and cine CT imaging
reveal, in both aneurysms and pseudoaneurysms, an
akinetic/dyskinetic segment in the LV wall [18, 19]. A
typical feature of pseudoaneurysm is that it has a narrow
ostium connecting them to the ventricle. In most cases, the
maximal width of the ostium is less than the maximal
parallel internal diameter [18].
True aneurysms will show late enhancement, which
indicates that their wall is formed by scar tissue secondary
to infarcted myocardial muscle. Owing to the fact that their
wall is composed only of pericardium, pseudoaneurysm
Fig. 2 True aneurysm in a patient with myocardial infarction. CECT
in the four-chamber axis demonstrates a large and thinning area of
akinesia in the anteroseptal-apical wall (arrow). A mural thrombus is
also observed in this aneurysm (asterisk)
Fig. 3 Apical ventricular remodelling in a patient with myocardial
infarction antecedent. Magnetic resonance imaging demonstrates left
ventricular (LV) dilation (white arrow) with distortion of its geometry
resulting in impairment in systolic function (EF: 28%)
Fig. 4 Apical ventricular remodelling. MRI in the short axis shows
the dilation of the ventricular apex and associated mural thrombus
(arrowhead)
Insights Imaging (2011) 2:471–482 473sacs do not show late enhancement; however, their border
will show enhancement, indicating a perianeurysmal in-
farcted area [17, 18]. There is often marked delayed
enhancement of the pericardium in pseudoaneurysms, and
it is uncommon or faint in true aneurysm, with a sensitivity
and specificity of 100% and 83%, respectively [18].
Associated mural thrombus is common in both aneurysms
and pseudoaneurysms (Fig. 2 and Video 3)[ 17, 18].
Apical diverticula
Apical diverticulum is a finger-like contractile pouch with
connection to the ventricle [19]. It is important to
differentiate apical diverticula from aneurysm and pseudoa-
neurysm. Ventricular diverticula are congenital, often
asymptomatic and are usually incidentally found while
performing diagnostic imaging procedures for other reasons
[20]. The wall of the diverticulum contains all layers of the
ventricular myocardium with preserved myocardial archi-
tecture [20]. Contrary to a LV aneurysm, this diverticulum
shows contraction during systole, because it contains a
muscular wall [19, 20]. Delayed enhancement is not seen.
In children, apical diverticula can be associated with
Cantrell’s syndrome, which is a rare syndrome characterised
by a partial sternal cleft, anterior abdominal wall defects,
anterior diaphragmatic defect and intracardiac defects of
which the ventricular septal defect is the most common and
Table 2 Relative merits of each non-invasive imaging technique for
the assessment of hypertrophic cardiomyopathy (HCM)
Factor assessed Echocar-
diography
a
Multi-detector
CT
MR
imaging
LV volume +++ ++ ++++
Ejection fraction +++ +++ ++++
LV filling
pressure
+++ - ++
Dynamic
obstruction
+++ + +++
IschemialCFR + - ++
Tissue
characterisation
++ + ++++
—The number of pluses indicates the relative usefulness of the modality.
-= modality is not useful, CFR = coronary flow reserve, PA = pulmonary
artery.
aData in this column are from Nagueh and Mahmarian [7]. Table
adapted from [3]
Fig. 5 Apical form of hypertro-
phic cardiomyopathy. Cine MRI
in the four-chamber view shows
progressive thickening of the
ventricular walls towards the
apex in diastole (a) and systole
(b). Late enhancement in a four-
chamber view (c) and vertical
long axis (d) demonstrates
strong enhancement in the
hypertrophied myocardium
(arrow). Note the presence of
“pseudo diverticulum” in the
most apical myocardium
(arrowhead)
474 Insights Imaging (2011) 2:471–482is invariably present. LV diverticulum is present in 20% to
50% of these cases [19].
Apical ventricular remodelling
Cardiac remodelling refers to the change in size, shape and
function of the heart after injury to the ventricles [16, 21,
22]. The injury is typically due to large acute myocardial
infarction depending on anterior descending coronary artery
occlusion. However, there are other non-ischaemic causes
(i.e. chronic pressure or chronic volume overload and
genetically determined cardiomyopathy) [21]. Myocardial
infarction promotes transformation of both infarcted and
non-infarcted regions, which leads to global LV dilation,
referred to as “ventricular remodelling”. It is a dynamic
process, starting in the acute phase with myocardial
thinning and lengthening of the infarcted area, progressing
to LV dilatation (Fig. 3) and hypertrophy of the non-
infarcted area [21, 22]. Dysfunction with increased
sphericity is common, as is the deposition of myocardial
fat [23] and the development of apical thrombus (Fig. 4
and Video 4)[ 21].
Apical hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a primary and
genetic myocardial disease characterised by a hypertro-
phied, non-dilated LV in the absence of another systemic or
cardiac disease (e.g. systemic hypertension, aortic valve
stenosis) capable of producing LV hypertrophy [1, 24].
There are several distinctive involvement patterns, one
variant being the apical hypertrophic cardiomyopathy
(AHC). Unlike usual HCM, AHC possesses typical clinical
features and has a relatively good prognosis. However, it
seems that the clinical course is less benign in western
countries than in Japan [9].
Cardiac MR imaging and multidetector CT are capable
of providing clinically useful information for the accurate
diagnosis of HCM, as well as for the determination of
clinical management strategies. However, MR imaging can
allow better characterisation of the pattern and distribution
of LV hypertrophy in HCM than in CT. Cardiac MR
imaging should be considered as the reference standard for
establishing a diagnosis of HCM when the results from
echocardiography are inconclusive or are suspected of
being false-negative findings. Moreover, cardiac MR
imaging is strongly recommended as a powerful imaging
technique for differentiating HCM from other cardiomyopa-
thies in the differential diagnosis (Table 2)[ 3].
The diagnosis is primarily based on the demonstration of
localised apical hypertrophy, defined as an end-diastolic LV
apical wall thickness greater than 15 mm or a ratio comparing
apical LVand basal LV wall thicknesses of ≥1.3–1.5 [25].
More subjective criteria for the diagnosis of AHC
include: obliteration of the LV apical cavity in systole,
failure to identify a normal progressive reduction in LV
wall thickness towards the apex [25] and apical aneurysm
formation with delayed enhancement [25, 26]. The forma-
tion of apical aneurysm is thought to be due to ischaemia,
which results from reduced capillary density, hyperplasia of
the arterial media, increased perivascular fibrosis and
myocardial bridging. This process usually occurs in the
presence of normal epicardial coronary arteries [25].
Patchy delayed enhancement in a mid-wall location is
present in most patients with HCM (Fig. 5)[ 25].
There are three types of apical HCM: (1) true apical
form (“spade-like” configuration), (2) involvement of the
apex and symmetric hypertrophy of the four ventricular
wall segments, and (3) involvement of the apex with
asymmetric involvement of the wall segments (“non-spade”
apical HCM) [27].
Table 3 Most frequent primary and secondary cardiomyopathies [4]
Primary cardiomyopathies
(mostly confined to the heart)
Secondary cardiomyopathies
(cardiac involvement is a part
of systemic disease)
Genetic: Infiltrative:
Hypertrophic Amyloidosis
Arrhythmogenic
Non-compaction
Mixed: Storage:
Dilated Hemochromatosis
Restricted
Acquired: Toxicity:
Inflammatory Drugs
Tako-Tsubo Chemical agents
Perip artum
Endocrine:
Diabetes mellitus
Hyperthyroidism
Hypothyroidism
Hyperparathyroidism
Pheochromocytoma
Acromegaly
Autoimmune/collagen:
Systemic lupus erythematosis
Dermatomyositis
Rheumatoid arthritis
Scleroderma
Polyarteritis nodosa
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Transient LV apical ballooning syndrome or Tako-Tsubo
cardiomyopathy (TSC) is a primary (Table 3)[ 24], acquired
and reversible cardiomyopathy that usually affects post-
menopausal women and is often provoked by a stressful
event or physical stress. This disorder shows clinical
features practically indistinguishable from acute myocardial
infarction in the absence of significant coronary artery
stenosis (which can be demonstrated by a normal CT
coronarography) with systolic dysfunction that is completely
reversible within a few days or weeks [24, 28].
The MR findings are characterised by LV myocardial
oedema with a diffuse and transmural distribution better
visualised on the STIR T2-weighted sequences as high
signal intensity (Figs. 6, 7) that matches with wall-motion
abnormalities seen on cine-MRI. Hypokinesis or akinesis in
the mid- and apical segments (although it can affect the
basal segments alone) of the LV causes “apical ballooning”
with compensatory basal segment hyperkinesis, taking the
name of Tako-Tsubo from the morphology of LV in the
ventriculography, which is similar to the Japanese pot used
to capture octopuses. These wall motion abnormalities can
produce a dynamic obstruction in the LV outflow (LVOT)
seen as a “jet” in the LVOT plane and also mitral
regurgitation [28].
Tako-Tsubo cardiomyopathy and acute myocardial infarc-
tion(Fig.8) can be clinically indistinguishable. Nevertheless,
the differential diagnosis of the disorders can be suspected
by the oedema location in the apical and mid-segments of
Fig. 6 A 72-year-old woman with Tako-Tsubo cardiomyopathy who
was seen in the emergency room for acute chest pain, raised cardiac
enzymes and ST elevation segments. Conventional coronarography
did not show significant epicardial stenosis. a STIR T2-weighted
images in the short-axis view show diffuse oedema in apical segments
with transmural location. Note how the mid and especially the basal
segments are spared. b Delayed enhancement sequence shows normal
and viable myocardium ruling out necrosis in the LV wall
Fig. 7 Tako-Tsubo cardiomyopathy in a 62-year-old woman. STIR
T2-weighted sequence in the vertical long-axis view shows the
characteristic location of oedema fully involving the apical segments
and sparing the basal segments
476 Insights Imaging (2011) 2:471–482LV that does not correlate with a vascular territory (Table 4)
[29], and TSC has rarely been reported to cause late
enhancement. Wall-motion abnormalities extend beyond the
region supplied by one coronary artery. This feature is
characteristic of Tako-Tsubo cardiomyopathy, whereas wall-
motion abnormalities observed in acute myocardial infarc-
tion are often more localised. Acute myocarditis can also be
clinically similar to TSC (acute chest pain, elevated cardiac
enzymes levels and ECG changes), but has a more diffuse,
heterogeneous distribution of the oedema (Fig. 9), often with
sub-epicardial affectation that may be accompanied by
pericardial enhancement [28].
Another characteristic feature of TSC is the lack of
hypoperfusion on the first-pass imaging and at rest and of
late enhancement on the delayed contrast sequence (Fig. 6)
in the LV segments where there is STIR spotted oedema,
which allows the differentiation from anterior ST elevation
myocardial infarction. A rare but serious complication is
the thrombus formation in the LV. The LV wall thickness is
normal [28].
In combination with clinical history and catheter-
isation findings, cardiac MR imaging can be useful in
supporting the diagnosis and monitoring functional
recovery [30]. MRI is also useful in differentiating Tako-
Tsubo cardiomyopathy from myocardial infarction and
myocarditis. Although coronary CT angiography is not
indicated in the initial evaluation of patients with
Tako-Tsubo cardiomyopathy, reports are emerging of the
use of coronary CT angiography in the subsequent
evaluation of patients with TSC [31].
Left ventricular non-compaction
LV non-compaction (LVNC) may be an isolated finding
(isolated left ventricular non-compaction)o rm a yb e
associated with other congenital heart anomalies (left
ventricular non-compaction). It is a congenital cardiomy-
opathy [24] characterised by a thickened wall with multiple
prominent ventricular trabeculations and deep intertrabecular
recesses (sinusoids) in communication with the ventricular
cavity, resulting in systolic and diastolic ventricular dysfunc-
tion. Non-compaction involves predominantly the apical
portion of the LV chamber, with or without right ventricular
involvement, due to an arrest in the normal embryogenesis
[32–34].
Fig. 8 A 68-year-old man with acute myocardial infarction. STIR T2-weighted images show high signal intensity (white arrow) due to ventricular
oedema that has a vascular distribution involving segments irrigated by the left anterior descending artery
Tako-Tsubo AMI Myocarditis
Hyperintensity
distribution in
T2-STIR
Transmural or diffuse Transmural or
subendocardial
Medium or
subepicardic
Location Apical and mid ventricular
segments without vascular
distribution
Vascular
distribution
Patchy, without
vascular distribution
Hyperintensity
durability in
T2-STTR
2 weeks More than 2 weeks
Table 4 Differences among
Tako-Tsubo, acute myocardial
infarction (AMI) and
myocarditis
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trabeculations, there is always the risk of over-diagnosis of
this disease. It is therefore essential to be thorough while
establishing the relationship between compacted and non-
compacted myocardium when the diagnosis of this entity is
being made. Using MRI, the most appropriate criteria would
be a ratio between non-compacted and compacted areas
greater than 2.3 (Fig. 10) in a diastolic long-axis view [35].
Although ventricular non-compaction can appear similar
to ventricular diverticula or prominent trabeculations (while
virtually always <3 in number in normal variants),
diagnosis of ventricular non-compaction usually requires
the finding of more than three deep intertrabecular recesses
in one imaging plane apically from the insertion of the
papillary muscles [20, 32, 36]. False tendons, dilated
cardiomyopathy, endocardial fibroelastosis and cardiac
Fig. 9 A 25-year-old man with
acute myocarditis. a STIR T2-
weighted sequence planned in
the vertical long axis and four-
chamber view showing oedema
with a different form of Tako-
Tsubo disease. The location of
the oedema is diffuse but af-
fecting all LV planes; also, the
appearance of the oedema is
patched. b Delayed enhance-
ment sequence in the four-
chamber view and post-contrast
balance sequence in the short-
axis view showing typical en-
hancement in the mid- and sub-
epicardial LV wall (arrows)
Fig. 10 Contrast-enhanced CT
in a patient with LV non-
compaction showing deep tra-
beculations in the apex of the
LV wall that define recesses
communicating with the main
ventricular chamber (arrows). In
this patient the ratio between
non-compacted and compacted
areas is 2.6 (diagnosis >2.3)
478 Insights Imaging (2011) 2:471–482metastases are other important differential diagnostic con-
siderations [34, 36].
Although echocardiography has been the diagnostic test
of choice for non-compaction, other techniques have been
used for the diagnosis, including CT and MRI [34].
Echocardiography may not visualise the apical region
optimally, leading to underestimation of the degree of left
ventricular non-compaction [37]. MRI provides good
correlation with echo for the localisation and extent of
non-compaction, and is useful in cases of poor echocardio-
graphic image quality. In addition, the demonstration of
differences in MRI signal intensity in non-compacted
myocardium may help identify substrates for potentially
lethal arrhythmias [34].
Arrhythmogenic right ventricular dysplasia
Arrhythmogenic right ventricular dysplasia (ARVD) is an
uncommon form of inheritable cardiomyopathy [24]a n d
is characterised by progressive loss of myocytes and
fibrofatty replacement of the right ventricular myocardium
[24, 38–41].
The diagnosis of ARVD is based on established criteria
determined by a task force comprising the European
Society of Cardiology and the International Society and
Federation of Cardiology [42].
The diagnosis of ARVD is based on the presence of
major and minor criteria (Table 5)[ 39, 42]. These criteria
include, in addition to personal and family history, 12-lead
ECG, echocardiography, right ventricular angiography,
cardiac magnetic resonance imaging and computerised
tomography [24, 39]. Although these criteria are specific,
they lack sensitivity and have never been validated, in
part because there is no single definitive means of
making the diagnosis [39]. Endomyocardial biopsy from
the right ventricular free wall is a sensitive diagnostic
marker when fibrofatty infiltration is associated with
surviving strands of myocytes [24] and is the preferred
method for making the diagnosis [39]. Experience with
Table 5 Diagnostic criteria for arrhythmogenic right ventricular dysplasia (ARVD)
Diagnostic criteria
I. Global and/or regional
dysfunction and structural
alterations
￿ Major
—Severe dilatation and reduction of right ventricular ejection fraction with no (or only mild) left and ventricular
impairment
—Localized right ventricular aneurysms (akinetic or dyskinetic areas with diastolic bulging)
—Severe segmental dilatation of the right ventricle
￿ Minor
—Mild global right ventricular dilatation and/or ejection fraction reduction with normal left ventricle
—Mild segmental dilatation of the right ventricle
—Regional right ventricular hypokinesia
II. Tissue characterisation
of walls
￿ Major
—Fibrofatty replacement of myocardium at endomyocardial biopsy
III. Repolarisation
abnormalities
￿ Minor
—Inverted T waves in right precordial leads (V2 and V3) (people >12 years old; in absence of right bundle
branch block)
IV. Depolarisation
of conduction
abnormalities
￿ Major
—Epsilon waves or localised prolongation (>110 ms) of the QRS complex in right precordial leads (V1—V3)
￿ Minor
—Late potentials (signal-averaged ECG)
V. Arrhythmias ￿ Minor
—Left bundle branch block type ventricular tachycardia (sustained or nonsustained; ECO, Holter, exercise
testing)
—Frequent ventricular extrasystoles on Holter (>1,000/24 h)
VI. Family history ￿ Major
—Familial disease confirmed at necropsy or surgery
￿ Minor
—Familial history of premature sudden death (at <35 years) due to suspected right ventricular cardiomyopathy
—Familial history (clinical diagnosis based on present criteria)
—Diagnosis is made if two major, or one major and two minor, or four minor criteria are satisfied. List is adapted from [42]
Insights Imaging (2011) 2:471–482 479CT in the diagnosis of ARVD is limited, but it has been
used in the detection of morphological abnormalities [38,
43, 44] and wall motion abnormalities, particularly in
patients with implantable defibrillators [43]. MRI is
established as the imaging technique of choice in the
assessment of ARVD [39, 44].
Reports of left ventricular involvement have led to the
recognition of ARVD as a diffuse disease of the heart
muscle affecting both ventricles [40, 41, 45, 46]. There is
evidence of LV involvement with fibrofatty replacement,
chamber enlargement and myocarditis in up to 75% of
patients [24]. Focal left ventricular dyskinesia can also be
present in the setting of fatty infiltration within the left
ventricle [39]. Late left ventricular enhancement has also
been described in patients with ARVD [39, 47]. In addition,
these changes can definitely affect the LV apex.
Left ventricular false tendons
Besides the normal papillary muscles and chordae tendinae,
in a minority of the population, false tendons or false
chordae occur as normal variants in the LV [48, 49]. They
might be single or multiple, usually thin, but sometimes
very prominent, leading to confusing echocardiograms.
They extend from the interventricular septum to the LV
free wall (Fig. 11), or rarely, from the septum to the
papillary muscle [36, 48, 50]. The LV false tendons are
seen with considerable frequency in the echocardiographic
evaluation of patients referred for having clinically innocent
heart murmurs. They have a fibrous or fibromuscular
structure (the thinner the tendon is, the higher fibrous
component they have, and at greater thickness, a greater
fibromuscular component) [48].
Apico-aortic conduit
Asaninfrequentfindingradiologistscoulddiscoverleftapical
devices secondary to iatrogenic manoeuvres that involve the
ventricular apex; one of them is the implantation of an LV
apico-aortic conduit (AAC) (Fig. 12), which is an alternative
approach for patients with aortic stenosis and conditions that
either preclude a median sternotomy or present a high risk of
aortic cross-clamping and aortotomy [51, 52]. It has three
components: an outflow graft to the descending aorta, a
valved conduit and an elbow apical connector. An apico-
aortic conduit decreases the LV aortic pressure gradient,
preserves or improves ventricular function, and maintains
Fig. 12 Apico-aortic bypass is
an alternative surgical option to
aortic valve replacement for
patients with a porcelain aorta or
LV outflow tract obstruction. It
is formed by a graft positioned
in the ventricular apex with a
valve into the conduit and anas-
tomosed to the thoracic aorta
(arrows)
Fig. 11 MRI in the four-chamber view showing a fibromuscular band
that stretches across the LV from the septum to a papillary muscle (false
tendon). This finding represents an anatomic variant that should not be
mistaken for abnormalities such as tumours, subaortic membranes,
thrombus borders or septal hypertrophy
480 Insights Imaging (2011) 2:471–482normally distributed blood flow through the systemic and
coronary circulation [53].
Conclusions
The diagnosis of diseases affecting the apex of the LV
can be challenging. This is mainly caused by the
technical limitations of echocardiography. CT and MRI
are non-invasive techniques that, because of their high
temporal and spatial resolution, are valuable in assess-
ing the apex of the LV, overcoming the technical
limitations of echocardiography and contributing to the
differential diagnosis (i.e. apical diverticula, aneurysms
and pseudoaneurysms).
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